Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Wavemaker Three-Sixty Health is a healthcare investment organization founded in 2017 in Los Angeles. The firm focuses on investing in healthcare disruptors and entrepreneurs who aim to transform the healthcare industry. Since its inception, Wavemaker has grown its portfolio to include 77 companies, demonstrating a strong commitment to supporting innovations in healthcare.
The organization operates across the United States, Canada, and Southeast Asia, connecting its portfolio companies with over 300 healthcare limited partners. This extensive network enhances commercial traction for the startups it supports. Wavemaker's fund size currently stands at $64 million, reflecting its growth and increasing influence in the healthcare investment space.
Notable milestones include achieving a portfolio valuation exceeding $2.5 billion by late 2022 and reaching the milestone of 50 investments in 50 months by HLTH 2022. The firm has established itself as a leading seed-stage healthcare pure-play venture capital firm.
Wavemaker Three-Sixty Health invests primarily in the healthcare sector, with a focus on health technology, digital health, medical technology, and pharmaceuticals. The firm supports companies at the seed and Series A stages, providing check sizes ranging from $200,000 to $1 million. Their investment strategy emphasizes innovations that improve patient experience, reduce costs, and enhance healthcare outcomes.
The organization’s investment thesis highlights the transition from fee-for-service to value-based care, leveraging technological advancements to address changing demographics and healthcare consumerism. Wavemaker seeks to partner with entrepreneurs who are dedicated to transforming the healthcare landscape through innovative solutions.
Wavemaker Three-Sixty Health's portfolio includes a diverse range of companies focused on healthcare innovation. Notable companies include:
The portfolio also features innovations in medical monitoring, personalized healthcare solutions, and technologies aimed at improving clinical trials and patient engagement. Wavemaker's investments reflect a commitment to supporting transformative healthcare solutions that address critical needs in the industry.
John Nackel: Founder and General Partner, with extensive experience in healthcare investments.
Tom Zenty: Executive-in-Residence, bringing a wealth of knowledge in healthcare management.
Bud Lawrence, MD: Venture Partner, with a background in medical technology and healthcare innovation.
Eric Marton: Senior Fund Advisor, specializing in strategic investment guidance.
Emily Ah Sing: Fund Administration, managing operational aspects of the fund.
Jay Goss: General Partner, contributing to investment strategy and portfolio management.
Monica Jain, MD: Venture Partner, focusing on healthcare solutions and innovations.
Anne Dordai: Head of Portfolio and Platform, overseeing portfolio company development.
Michelle Wang: Senior Associate, involved in deal sourcing and evaluation.
Maxim Owen: Partner, with expertise in healthcare investments.
Kwame Ulmer: Venture Partner, focusing on healthcare startups.
Matt Michelson, PhD: AI Technologist-in-Residence, specializing in AI applications in healthcare.
Brian Kadota: Director of Venture Operations, managing operational functions within the firm.
Dan Hirschfeld: Council of Strategic Advisors, specializing in post-acute care.
Harlan Levine, M.D.: Council of Strategic Advisors, focusing on health innovation and policy.
Harry Nelson: Council of Strategic Advisors, with expertise in regulatory and risk management.
Jason Sussman: Council of Strategic Advisors, specializing in hospitals and health systems.
Marc Alba: Council of Strategic Advisors, focusing on disruption and technology.
Ravi Kumar: Council of Strategic Advisors, specializing in healthcare M&A.
Tina Modi: Council of Strategic Advisors, focusing on healthcare strategy.
Startups interested in pitching to Wavemaker Three-Sixty Health should visit their website to submit applications. The firm prefers detailed decks that outline the business model, market opportunity, and how the innovation addresses specific healthcare challenges. Response times may vary, but founders are encouraged to provide a warm introduction if possible to increase their chances of engagement.
In November 2024, Wavemaker Three-Sixty Health made a seed investment in Citizen Health, continuing its trend of supporting innovative healthcare startups. The firm co-led a Series A investment in UptimeHealth alongside Caduceus Capital Partners, further expanding its portfolio.
Wavemaker has achieved significant milestones, including reaching 77 investments and facilitating over $750 million in follow-on funding for its portfolio companies. By late 2022, the portfolio had exceeded a valuation of $2.5 billion, showcasing the firm's successful investment strategy.
What are Wavemaker Three-Sixty Health's investment criteria?
Wavemaker focuses on healthcare disruptors and entrepreneurs at the seed and Series A stages. They invest in sectors such as health technology, digital health, medical technology, and pharmaceuticals, with check sizes ranging from $200,000 to $1 million.
How can startups apply or pitch to Wavemaker?
Startups can submit their pitches through the Wavemaker Three-Sixty Health website. It is recommended to include a clear business model, market analysis, and details on how the innovation improves patient outcomes or reduces costs.
What makes Wavemaker Three-Sixty Health different from other VC firms?
Wavemaker has a unique focus on healthcare, connecting its portfolio companies with over 300 healthcare limited partners to enhance commercial traction. Their emphasis on value-based care and technological advancements sets them apart in the venture capital landscape.
What is Wavemaker's geographic scope?
The firm operates primarily in the United States, Canada, and Southeast Asia, allowing them to tap into diverse healthcare markets and innovations.
What kind of post-investment involvement does Wavemaker have?
Wavemaker actively engages with its portfolio companies, providing strategic guidance and facilitating connections that enhance commercial opportunities. Their extensive network supports startups in achieving their growth objectives.
What is the fund size and how much has been deployed?
Wavemaker's current fund size is $64 million, and they have deployed over $20 million into their portfolio, demonstrating strong follow-on traction for their investments.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.